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Abstract:
Life chaos, the perceived inability to plan for and anticipate the future, 
may be a barrier to the HIV care continuum for people living with HIV 
who experience incarceration. Between December 2012 and June 
2015, we interviewed 356 adult cis-men and transgender women living
with HIV in Los Angeles County Jail. We assessed life chaos using the 
Confusion, Hubbub, and Order Scale (CHAOS). We conducted 
regression analyses to estimate the association between life chaos and
care continuum. Forty-eight percent were diagnosed with HIV while 
incarcerated, 14% were engaged in care 12 months prior to 
incarceration, mean antiretroviral adherence was 65%, and 68% were 
virologically suppressed. Adjusting for sociodemographics, HIV stigma, 
and social support, higher life chaos was associated with greater 
likelihood of diagnosis while incarcerated, lower likelihood of 
engagement in care, and lower adherence. There was no statistically 
significant association between life chaos and virologic suppression. 
Identifying life chaos in criminal-justice involved populations and 
intervening on it may improve continuum outcomes. 
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Introduction
The HIV epidemic disproportionately affects the incarcerated 
population in the US, with a 1.3% seroprevalence that is approximately
three times that of the general population [1]. Furthermore, compared 
to people living with HIV (PLH) in the US general population, 
incarcerated PLH are often less likely to have achieved HIV care 
continuum milestones [2, 3] – engaged in care, received and adhered 
to antiretroviral therapy (ART) and achieved virologic suppression - at 
the time of incarceration [4-7]. The disproportionate burden as well as 
the profound challenges in achieving the care continuum reflect how 
the incarcerated population represents one of the most socially and 
economically marginalized individuals in the US [8-10]. Understanding 
the lived experience of navigating social and structural barriers to care,
such as the sense of unpredictability of daily life or insecurity in 
housing and income, may help us improve the HIV care continuum 
among incarcerated PLH.  
The idea that life chaos – perceived inability to plan for and 
anticipate the future - leads to adverse outcomes was first proposed by
Matheny and colleagues in the field of child development [11]. Their 
tool, the Confusion, Hubbub, and Order Scale (CHAOS), has since been 
adapted to adults to measure various aspects of stability and 
predictability in daily life, ranging from a person’s perceived ability to 
organize a routine and keep a schedule, to their sense of certainty 
regarding their future housing or source of income [12]. While life 
chaos remains an underexplored concept in the health literature, a few
previous studies have demonstrated that it predicts important health 
outcomes. Life chaos predicted missed appointments and poor 
medication adherence among PLH [12, 13], and patients with chronic 
illness, [14, 15] as well as risky sexual behavior among men who have 
sex with men (MSM) [16]. In addition, life chaos was associated with 
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structural barriers to HIV care –  poverty, homelessness, and having 
unmet needs for financial, employment, and food support services –  
supporting its validity [12, 13].  
The literature on criminal justice-involved people living with HIV 
describes high levels of chaos in their lives. They frequently experience
poverty, comorbid substance use disorder [17, 18] housing instability
[19], and social isolation from HIV stigma, all of which may lead to life 
chaos [13, 16, 20]. Many come from communities where households 
and relationships are disrupted from high rates of incarceration [21]. 
Finally, social and economic marginalization due to overlapping 
stigmatized identities likely compound the life chaos; for example, 
transgender women experience discrimination in employment, 
healthcare and family settings and victimization while incarcerated
[22, 23].
Guided by the ecosocial theory that posits the importance of 
examining health inequities in the context of individual, interpersonal, 
and structural factors [24], we highlight two interpersonal factors that 
are known to shape the HIV epidemic among incarcerated PLH: social 
support and HIV-related stigma. Supportive social relationships have 
been shown to be positively associated with protective HIV-related 
behaviors, fewer HIV infections, and better HIV care continuum 
outcomes in general [25-29], including for incarcerated PLH [18, 30, 
31].  Social support provides material resources or emotional support 
to buffer the effects of stressors [32, 33], and can potentially counter 
the effects of life chaos [16].  On the other hand, social relationships 
are a source of HIV-related stigma, the devaluation and discrimination 
of PLH, which can be a potent barrier to continuum of care outcomes.
[34, 35] For PLH with criminal-justice involvement, HIV-related stigma 
is associated with hiding one’s HIV serostatus, refusing to take ART, 
and relapsing into substance use [18, 30, 31, 36].
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Using baseline data collected from a sample of PLH entering the Los
Angeles County jail who participated in a randomized controlled trial of 
a peer navigation intervention after release from jail, we examined 
whether life chaos, social support, and HIV-related stigma prior to 
incarceration were associated with HIV care continuum engagement 
upon entry into jail. We hypothesized that life chaos was associated 
with each of the HIV care continuum steps. 
Methods
Study setting and population
This study is based on the baseline data collected for the LINK LA 
study, a two-group, randomized trial of a peer navigation intervention 
for PLH released from jail, as previously published [37]. To summarize 
briefly, we recruited participants from Los Angeles County Jail, where 
inmates were routinely screened for HIV at intake. They were eligible 
for study participation if they were: (1) HIV seropositive; (2) age 18 or 
older (3) cis-men or transgender women; (4) English- or bilingual 
Spanish-speaking; (5) planning to reside in LA County upon release; 
and (6) eligible for antiretroviral therapy or incarcerated on 
antiretroviral therapy [37]. Exclusion criteria were: (1) inability to give 
informed consent; (2) planned transfer to prison; and (3) stay in jail <5
days. Of a total of 465 potentially eligible persons, we enrolled 356 in 
the study (105 were screened, but not eligible and 4 declined). 
Data collection
From December 2012 through June 2015, research staff conducted 
face-to-face baseline interviews approximately one week prior to 
release from jail.  The team also obtained electronic medical record 
data on HIV viral load, which was routinely drawn several days after 
the participants diagnosed with or known to have HIV arrived at jail. 
Participants were compensated $25 for the interview.
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Primary variables of interest
Primary dependent variables were achievement of steps in the HIV 
care continuum prior to the jail stay [38]: routine HIV testing in the 
community (vs. only while incarcerated), engagement in care, ART 
adherence, and viral suppression. To identify those who did not 
participate in routine HIV testing, we asked whether the participant 
first tested positive for HIV during the current or a previous 
incarceration in jail or prison: participants who tested positive while 
incarcerated were deemed not to have achieved that milestone. To 
measure engagement in care, we asked whether the participant had 
received at least one HIV primary care visit in the community 12 
months prior to entering jail. ART adherence over the 30 days prior to 
incarceration was measured on a scale of 0-100% rating scale, 
generally called a Visual Analog Scale [39-41]. Finally, we defined 
virologic suppression as viral load <400 copies/ml on first viral load 
after jail entry. This cutoff was selected to account for viral blips that 
do not result in any clinically significant viral replication [5, 42, 43]. 
The primary independent variables included measures of life chaos, 
social support, and HIV-related stigma (see appendix). To measure life 
chaos, we administered the 12-item Confusion, Hubbub, and Order 
Scale (CHAOS) adapted for adults, which measures predictability of life 
circumstances, ability to plan and anticipate the future, and reliability 
of income, employment, housing [12]. In this analysis, we excluded 2 
items about certainty of employment in 6 months, given that the 
participants were incarcerated and unemployed at the time of 
interview. Each item was scored on a 5-point Likert-type scale ranging 
from “definitely true” to “definitely false.” The items were averaged for
the total score (from 1-5), with higher numbers representing more 
chaos. The final 10-item chaos scale in this analysis showed acceptable
internal consistency reliability (Cronbach’s alpha = 0.76). 
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We measured social support using a 5-item scale that was derived 
from a previous tool designed to measure perceived availability of 
emotional and practical support [44-46]. Each item was scored on a 5-
point Likert-type scale ranging from “none of the time” to “all of the 
time.” The scale showed excellent internal consistency reliability 
(Cronbach’s alpha = 0.90). The items were averaged to create a scale 
score (from 1-5), with higher values represent greater social support.
We measured HIV-related stigma using a 12-item version of an 
established measure that taps four dimensions of stigma: negative 
stereotypes associated with HIV, disclosure concerns, treatment by 
others, and internalization of shame [47, 48].  Each item was scored on
a 5-point Likert-type scale ranging from “none of the time” to “all of 
the time.” The items were averaged to create a scale score (from 1-5), 
with higher values representing greater stigma. The scale showed 
acceptable internal consistency reliability (Cronbach’s alpha = 0.80). 
Other explanatory variables
Sociodemographic variables included age, race/ethnicity, 
educational attainment, annual household income, health insurance 
status, risk/gender group, and HIV transmission risk category. 
Educational attainment was dichotomized into participants who had 
less than high school education, and those who had completed high 
school or equivalent. Individual annual income was dichotomized at 
$10,000 or less and greater than $10,000, with the cutoff based on the
median income of the sample. Health insurance was dichotomized at 
any insurance (private, Medicare, Medicaid, other) vs none. 
Participants were assigned mutually-exclusive categories based on 
their gender and HIV transmission risk factor: male-to-female 
transgender, men who have sex with men, men who have sex with 
women, or people who used injection drugs. We also included SF-12 
mental health composite scores [49]. 
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Statistical Analysis
The scales for life chaos, social support, and HIV-related stigma, 
were centered by subtracting the sample mean from scores. 
We used logistic regression analyses to estimate the dichotomous 
continuum of care outcomes: HIV diagnosis while incarcerated, 
engagement in care prior to incarceration, and viral suppression. We 
used linear regression analysis for level of ART adherence. We 
examined factors associated with HIV diagnosis while incarcerated 
among all participants (n = 356) and examined correlates of the three 
remaining outcomes only among participants who were diagnosed with
HIV prior to the current incarceration (n = 321). We first conducted 
bivariate regression analyses to estimate the association between HIV 
continuum outcomes and each of the variables described above. We 
then conducted multivariable analyses in which each HIV care 
continuum outcome was specified as a function of the explanatory 
variables described above. As an alternative way to interpret the 
logistic regression models[50], we estimated marginal effects, defined 
as the effect of a small change in life chaos on the probability of 
achieving HIV care continuum outcomes [51]. The regression models 
were fitted to complete-case data. 
We also conducted sensitivity analysis by adding several variables 
to the regression models for each dependent variable and examined its
effect on the previously observed associations. First, we added the 
interaction variables: life chaos * social support and life chaos * stigma,
into separate multivariable models. We used these interaction 
variables to examine whether the associations between life chaos and 
HIV care continuum outcomes changed by the level of social support 
and the level of stigma, respectively. In separate multivariable models,
we added CD4 count as sensitivity analyses.  Because the estimates 
for the main independent variables were robust to this change, we 
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present the original models with the primary independent variables 
and covariates as described above. Finally, we conducted sensitivity 
analysis using multiple imputation for the 90 missing (nonresponse) 
ART adherence values among those who were prescribed ART prior to 
incarceration, by creating 10 imputed data sets using the multivariate 
normal (MVN) distribution command in STATA v.9.4.
Statistical analyses were conducted using SAS v9.4; marginal effect 
estimates for logistic regression models and multiple imputation 
procedures were conducted using STATA v15.0 [52].
Results
Participant Characteristics
We interviewed 356 participants. One hundred and fifty-one (42%) 
participants were Black/African American and 110 (31%) were 
Hispanic/Latino (Table I). The median age of the respondents was 40. 
Most respondents were MSM (56%), 37% did not graduate from high 
school, 42% earned $10,000 or less annually, 55% had no health 
insurance, and 11% had CD4 count less than 500. Regarding HIV care 
continuum outcomes (Table II), 172 (48%) participants were diagnosed
while incarcerated, of which 35 (20%) were diagnosed during this 
incarceration. Of the participants who were diagnosed prior to this 
incarceration, 46 (14%) had engaged in care in the past 12 months, 
and 218 (68%) of participants were virologically suppressed at the time
of incarceration. The mean self-reported percentage of ART adherence 
was 65%. The mean (standard deviation) for the scales (scored from 1-
5) were as follows: life chaos 3.25 (1.29), social support 2.65 (0.86), 
and HIV-related stigma 2.59 (0.79). 
Correlates of HIV diagnosis while incarcerated
In bivariate analyses, life chaos (OR = 1.35, 95% CI 1.05 to 1.73 was
associated with higher odds of having been diagnosed with HIV while 
incarcerated, while having completed high school (OR = 0.62, 95% CI 
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0.41 to 0.96), and having public health insurance compared to having 
private insurance or no insurance (OR = 0.60, 95% CI 0.39 to 0.92) 
were associated with lower odds (Table III). In the multivariable model, 
life chaos (aOR=1.52, 95% CI 1.09 to 2.11) was associated with higher 
odds of having been diagnosed with HIV while incarcerated, while 
having completed high school was associated with lower odds (aOR = 
0.54, 95% CI 0.32 to 0.80). Average marginal effects estimates showed
that an increase in 1 point on the chaos scale increases the probability 
of diagnosis while incarcerated by about 10 percentage points; for 
example, increasing chaos from 3 to 4 on the 5-point scale would 
change this probability from 51% to 61%. 
Correlates of engagement in care prior to incarceration
In bivariate analyses, life chaos (OR = 0.56, 95% CI 0.39 to 0.81) 
and Hispanic/Latino ethnicity  (OR = 0.38, 95% CI 0.15 to 0.93) were 
associated with lower odds of engagement in care prior to entering jail,
while older age (OR = 1.05, 95% CI 1.02 to 1.09), annual income over 
$10,000 (OR = 3.15, 95% CI 1.50 to 6.61), and having public (OR = 
2.57, 95% CI 1.21 to 5.57) or private health insurance (OR = 7.09, 95%
CI 2.87 to 17.51) were associated with higher odds (Table III). In the 
multivariable model, life chaos remained associated with lower odds of 
engagement in care prior to incarceration (aOR=0.53, 95% CI 0.32 to 
0.87), as did older age (aOR = 1.06, 95% CI 1.02 to 1.10), annual 
income over $10,000 (aOR = 2.30, 95% CI 1.01 to 5.23), and private 
health insurance (aOR = 5.59, 95% CI 2.04 to 15.29) were associated 
with higher odds. Average marginal effects estimates showed that an 
increase in 1 point on the chaos scale decreases the probability of 
diagnosis while incarcerated by about 6 percentage points; for 
example, increasing chaos from 3 to 4 on the 5-point scale would 
change this likelihood from 9.5% to 5.6%. 
Correlates of antiretroviral therapy adherence
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In bivariate analyses, life chaos (b = -12.39, 95% CI -18.90 to -5.89),
HIV-related stigma (b = -8.10, 95% CI -14.97 to -1.23), being a man 
who has sex with men (b = -16.21, 95% CI -30.81 to -1.61) and having 
public health insurance (b = -12.53, 95% CI -24.37 to -0.69) were 
associated with lower ART adherence.  The SF12 mental component 
score (b = 0.54, 95% CI 0.10 to 0.99) was associated with higher ART 
adherence (Table IV). In the multivariable model, life chaos (b = -8.68, 
95% CI -16.90 to -0.46) associated with lower ART adherence, 
representing an almost 9% decrease in self-reported adherence per 
one-point increase in the life chaos scale. Other covariates associated 
with lower ART adherence were being a MSM (b = -17.68, 95% CI -
34.65 to -0.70), and having public health insurance (b = -14.28, 95% CI
-26.09 to -2.47). 
Sensitivity analysis using multiple imputation of ART adherence is 
shown in Appendix Table I. In bivariate analyses, life chaos, HIV-related
stigma, being male to female transgender, and being an MSM were all 
associated with lower ART adherence, while SF12 mental component 
score was associated with higher adherence.  In the multivariable 
model, life chaos and being an MSM was associated with lower ART 
adherence.
Correlates of virologic suppression at incarceration
In bivariate analyses, HIV-related stigma (OR = 0.69, 95% CI 0.51 to
0.93) was associated with lower odds, and SF12 mental component 
score (OR = 1.03, 95% CI 1.01 to 1.05) was associated with higher 
odds of virologic suppression (Table III). In the multivariable model, 
Black/African American race remained associated with lower odds of 
virologic suppression (aOR = 0.47, 95% CI 0.24 to 0.93). Life chaos was
not significantly associated with virological suppression. 
Additional sensitivity analysis containing life chaos * social support 
and life chaos * HIV-related stigma interaction variables for 
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multivariable logistic models, and multivariable linear regression 
models with complete case and multiple imputation for ART adherence 
are shown in Appendix Tables 2 and 3. The main effects of life chaos 
on HIV diagnosis while incarcerated, engagement in care, and ART 
adherence remained robust to the inclusion of these variables.
Discussion
While correctional facilities represent an important opportunity to 
address the HIV care continuum among vulnerable populations [53, 
54], our study among cis-men and transgender women PLH in LA 
county jail showed significant gaps in the HIV care continuum prior to 
and upon entry into incarceration. Life chaos – the perception of having
an unstable, unpredictable, disorganized life – was associated with 
elevated odds of HIV diagnosis while incarcerated among all 
participants, and with reduced odds of engagement in care and lower 
ART adherence among participants who were already diagnosed with 
HIV.  However, our study did not support the hypothesized association 
of life chaos with viral suppression. The substantial associations of life 
chaos with several HIV care continuum variables remained significant 
and robust to the inclusion of multiple covariates that reflected the 
social environment of this vulnerable group of PLH. 
Consistent with our hypotheses, life chaos was associated with 
greater odds of being first diagnosed with HIV while incarcerated. 
Almost half of our participants were diagnosed with HIV during the 
current or prior incarceration rather than during routine testing in the 
community, reflecting the concentration of medically-underserved 
individuals in the criminal justice system [54]. Routine HIV screening is 
critical not only for timely linkage to care and treatment for PLH, but 
also for reducing unrecognized transmission of HIV to others in the 
community [38]. HIV screening for those who are seronegative can also
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be opportunities for risk assessment, counseling and intervention such 
as pre-exposure prophylaxis to prevent acquisition of HIV [55].
Further consistent with our hypotheses, life chaos was associated
with poor engagement in care, which was common in this vulnerable 
population. Eighty-five percent of the participants who had known HIV 
infection had not engaged in care in the community during the 12 
months prior to incarceration, similar to findings from a recent 
systematic review on incarcerated PLH [7]. 
Finally, each one-point increase in the life chaos scale was 
associated with a 9% decrease in adherence, a finding that was 
reproducible in the multiple imputation sensitivity analysis. The self-
reported mean ART adherence was 65% among those with known HIV 
infection and prescribed ARTs, comparable to levels reported in other 
studies [7]. 
In contrast, life chaos was not statistically significantly associated 
with virologic suppression. While we do not know why this occurred in 
our study, one explanation may be that virologic suppression, 
especially when measured using a single measurement [59], is a 
downstream outcome that is not sensitive to the effects of upstream 
processes of engagement in care and adherence. Hence, life chaos 
may correlate with poor engagement in care and adherence to ART, 
but these processes may not be ultimately reflected in the viral load. 
First, virologic suppression is seen among patients with significant care
gaps. In our study, 15% were engaged in care, while 32% were 
virologically suppressed. A recent study demonstrated a similar 
apparent discrepancy: a care gap of less than 9 months had no 
association on viral load, and a gap of 12 months or more resulted in a 
quarter of previously suppressed patients becoming unsuppressed
[56]. One explanation for this observation is that patients continue to 
take ART despite not engaging in care: a recent study based on a 
12
billings claim database showed that 40% of addition, virologic 
suppression is seen among patients with moderate levels of ART 
adherence. Further, studies have shown that moderate levels of 
adherence as low as 75% can lead to virologic suppression [60-62]. 
Finally, reincarceration is common [58]. It is possible that participants 
received care and took ART during a previous jail stay within the 12 
months prior to the current incarceration, and this may not have been 
reflected in the survey results.While life chaos is an underexplored 
concept, the literatures on some related concepts may shed light to 
potential mechanisms through which life chaos may be linked to care 
continuum outcomes. The perception that the future is uncertain is a 
central component of life chaos; similarly, time preference theory 
proposes that those who perceive that the future is uncertain are less 
likely to engage in healthy behaviors, because they do not value the 
potential health benefit in the future [63]. If chaos in effect measures 
future uncertainty, the association we found between chaos and HIV 
testing, engagement in care, and ART adherence may reflect our 
participant’s lack of perceived benefit of these health-promoting 
activities. Another conceptually similar measure, stressful life 
circumstances (such as employment difficulties and major financial 
problems) predicted poor ART adherence [64]. Finally, life chaos has 
been closely linked to underlying poverty[13] as well as with unmet 
needs in housing, finances, employment, and food security [12, 54]. 
Prior studies showed that incarcerated PLH who are homeless [2, 65] or
otherwise have difficulty meeting basic needs [53, 66] are less likely to
receive routine HIV care. Homelessness [58, 65] and food insecurity 
have been associated with poor ART adherence [3], while employment 
has been associated with increased adherence [2] for incarcerated 
PLH. 
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After adjusting for covariates, we did not find meaningful 
relationships of our measured gender categories with any of our HIV 
care continuum variables between transgender women and cis-men. A 
recent multi-site study among criminal-justice involved PLH similarly 
found no significant difference in ART adherence or viral suppression 
between cis-men and transgender women [67]. The same study found 
that transgender women were more likely to engage in HIV 
transmission risk behaviors compare to cis-men. Transgender women 
experience disproportionate burden of HIV [68], and risk behaviors 
may drive gender disparities among criminal justice-involved PLH. 
Our findings have important implications for researchers, health 
care providers and policy makers. At the individual level, our findings 
demonstrate the potential benefit of novel approaches to understand 
and address life chaos for PLH who experience incarceration in order to
achieve HIV care continuum goals. Health care providers may identify 
patients who show signs of life chaos, such as having difficulty keeping
their appointments or reluctance to schedule their next appointment, 
and offer supportive services, especially if they have experienced 
incarceration. Providers could partner with peer navigators or 
community health workers who may assist PLH in managing their life 
chaos, such as by scheduling or reminding them of their appointments 
or organizing transportation [37], thereby making health care a source 
of stability. It would be critical to identify and address life chaos among
PLH prior to their arriving in jail. It will be important to examine 
whether interventions that target the underlying structural barriers 
associated with life chaos, such as housing, food, and income, will 
change the perceptions of insecurity and uncertainty among 
vulnerable people, and also lead to better continuum of care outcomes
in well-designed prospective studies. At the community level, this may 
include addressing incarceration stigma – shame and discrimination of 
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people who experience incarceration [53, 69, 70] – as this has been 
found be to a barrier for formerly incarcerated PLH to accessing care 
and other resources, such as housing, employment, and educational 
opportunities. 
Interpretation of our findings is subject to limitations. First, our data 
are cross-sectional, which limits our ability to make causal inferences. 
Second, the interview was done prior to release from jail, so some 
participants may incorrectly recall their history prior to incarceration. 
While the restrictive environment of incarceration [18] may color their 
recollection of life chaos prior to incarceration, our mean chaos score 
was similar to that found among under-resourced PLH in Los Angeles
[12]. The data on HIV testing, engagement in care, and ART adherence
are self-reported, and therefore subject to the challenges inherent to 
all studies using self-reported data. We did not collect data on 
reincarceration. While interviews were conducted in a confidential 
manner, data may be biased with respect to the participants’ 
willingness to report poor adherence and engagement with care. 
Finally, our results may not be generalizable to populations outside of 
Los Angeles County. 
Despite these limitations, we conclude that, in this study of cis-
gendered men and transgendered women incarcerated in a large 
municipal Jail, we found that life chaos was associated with gaps in the 
HIV care continuum prior to entering jail. Prospective studies, including
intervention studies, will be needed to establish life chaos as a 
predictor of continuum outcomes. If life chaos is found to predict HIV 
care continuum outcomes, then policy makers and clinicians should 
provide supportive services to help PLH manage life chaos as well as 
address underlying structural issues such as housing and income.
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Table I Sociodemographic characteristics of HIV-positive cis-men and
transgender women prior to incarceration in LA County Jail (N = 356)a
Variable n (percent) or mean 
(SD)
Demographic variables
Age
Age 30 or younger 86 (24%)
31 - 40 95 (27%)
41 – 50 118 (33%)
51 and older 57 (16%)
Race/ethnicity
Black/African American 151 (42%)
Hispanic/Latino 110 (31%)
Other 95 (27%)
HIV-transmission Risk group
Men who have sex with men 201 (56%)
Male-to-female transgender 53 (15%)
Injection drug use 43 (12%) 
Men who have sex with women 59 (17%)
Educational attainment
Less than high school graduation 131 (37%)
High school graduation or equivalent 96 (27%)
Some college or more 128 (36%)
Annual income
$10,000 or less 150 (42%)
$10,001 - $ 20,000 96 (27%)
$20,001 - $30,000 38 (11%)
$30,001 - $50,000 23 (6%)
More than $50,000 48 (14%)
Health insurance
No health insurance 191 (55%)
Low Income Health Program (Healthy Way LA) 43 (12%)
24
Medicaid/Medi-Cal 77 (22%)
Private 17 (5%)
Other 18 (5%)
CD4 count
<200 38 (11%)
200-349 54 (15%)
350 - 499 88 (25%)
Greater than or equal to 500 175 (49%)
SF 12
Mental Component Scale 38.2 (12.3)
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Table II HIV care continuum variables and social environment
characteristics by gender of HIV-positive cis-men and transgender
women prior to incarceration in LA County Jail (N = 356)a
Variable n (percent) or mean (SD)
HIV Care Continuum Variables Overall Cis-men MTF
Engagement in care in the past 12 
months, among those diagnosed 
prior to this incarceration
Yes 46 (14%) 39 (14%) 7 (14%)
HIV diagnosis while incarcerated
Yes 172 (48%) 146 
(48%)
26 (49%)
Diagnosis during this incarceration 35 (10%) 32 (11%) 3 (6%)
Virologic suppression (viral load < 
400cpm) among those diagnosed 
prior to this incarceration
Yes 218 (68%) 189 
(70%)
29 (58%)
Percentage ART adherence 65.0 
(39.3)
66.2 
(39.4)
56.8 
(38.6)
Independent variables
Life chaos score * 3.25 
(1.29)
3.21 
(0.88)
3.51 
(0.65)
Social support score 2.65 
(0.86)
2.69 
(1.31)
2.42 
(1.18)
HIV-related stigma score 2.59 
(0.79)
2.57 
(0.81)
2.71 
(0.66)
MTF: male to female transgender
a. The following number of observations were missing these variables: engagement in 
care (3 observations), ART adherence (90 observations, 24 observations not 
prescribed ART), HIV-related stigma (31 observations), and social support (3 
observations)
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* p<0.05 by independent group t-test comparing means between cis-men and 
transgender women or Pearson chi-square test for independence between gender 
identity and frequency of variable
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Table III: Multivariable logistic regression models of associations of life chaos, social support, and
HIV-related stigma with HIV diagnosis while incarcerated, engagement in care, and virologic
suppression among HIV-positive cis-men and transgender women prior to incarceration in LA County
Jail a
HIV diagnosis while 
incarcerated (N = 311)
Engagement in care (N = 304) virologic suppression (N = 307)
Variables Bivariate Multivariable Bivariate Multivariable Bivariate Multivariable 
OR (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI) OR (95% CI) aOR (95% CI)
Life chaos 1.35 (1.05, 
1.73)* 
1.52 (1.09, 
1011)*
0.56 (0.39, 
0.81)***
0.53 (0.32, 
0.87)* 
0.77 (0.58, 
1.02)
1.06 (0.75, 1.52)
Social support 0.93 (0.79, 
1.10)
0.89 (0.73, 
1.09)
1.20 (0.94, 1.53) 1.23 (0.91, 
1.65)
1.18 (0.98, 
1.43)
1.13 (0.91, 1.41)
HIV stigma 0.99 (0.75, 
1.31)
0.91 (0.65, 
1.28)
0.79 (0.53, 1.19) 1.18 (0.67, 
2.06)
0.69 (0.51, 
0.93)*
0.82 (0.57, 1.17)
Age 0.99 (0.97, 
1.01)
1.01 (0.98, 
1.04)
1.05 (1.02, 
1.09)***
1.06 (1.02, 
1.10)** 
1.02 (0.999, 
1.04)
1.01 (0.98, 1.04)
Race/ethnicity
Black 1.46 (0.87, 
2.44)
1.53 (0.82, 
2.88)
0.75 (0.37, 1.52) 0.75 (0.31, 
1.83)
0.55 (0.31, 
1.00)
0.47 (0.24, 
0.93)*
Hispanic 1.54 (0.89, 
2.69)
1.56 (0.80, 
3.05)
0.38 (0.15, 
0.93)*
0.41 (0.14, 
1.23)
0.79 (0.41, 
1.52)
0.96 (0.46, 1.99)
Other (ref)
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Risk/gender 
group
MTF 0.76 (0.36, 
1.60)
0.53 (0.22, 
1.26)
1.25 (0.39, 4.01) 3.62 (0.81, 
16.19)
0.53 (0.23, 
1.20)
0.54 (0.21, 1.36)
MSM 0.67 (0.37, 
1.19)
0.60 (0.29, 
1.23)
1.33 (0.52, 3.43) 2.29 (0.66, 
7.95)
0.81 (0.41, 
1.59)
0.61 (0.28, 1.34)
Injection drug 
use
0.75 (0.34, 
1.66)
0.84 (0.33, 
2.10)
1.63 (0.50, 5.28) 2.16 (0.49, 
9.47)
1.15 (0.46, 
2.93)
0.71 (0.25, 2.00)
MSF (ref)
Educational 
attainment
Did not 
complete high
school (ref)
Completed 
high school
0.62 (0.41, 
0.96)*
0.54 (0.32, 
0.89)* 
1.52 (0.77, 3.03) 1.33 (0.60, 
2.96)
1.24 (0.76, 
2.00)
1.23 (0.71, 2.12)
Annual income
$10,000 or 
less (ref)
Greater than 
$10,000
1.23 (0.81, 
1.88)
1.35 (0.83, 
2.28)
3.15 (1.50, 
6.61)**
2.30 (1.01, 
5.23)* 
1.35 (0.87, 
2.11)
1.44 (0.84, 2.48)
Health 
insurance
29
No health 
insurance (ref)
Public health 
insurance
0.51 (0.32, 
0.82) ** 
0.78 (0.46, 
1.31)
2.57 (1.21, 
5.57)* 
2.12 (0.91, 
4.92)
1.05 (0.63, 
1.75)
1.06 (0.60, 1.85)
Private health 
insurance
1.02 (0.49, 
2.09)
1.65 (0.74, 
3.67)
7.09 (2.87, 
17.51)*** 
5.59 (2.04, 
15.29)** 
0.91 (0.42, 
1.96)
0.83 (0.36, 1.91)
SF12 MCS 1.01 (0.995, 
1.03)
1.02 (1.00, 
1.04)
0.99 (0.97, 1.02) 0.97 (0.94, 
1.00)
1.03 (1.01, 
1.05)**
1.02 (1.00, 1.05)
* = p<0.05, ** = p <0.01, *** = p<0.001
MTF: male to female transgender; MSM: men who have sex with men; MSF: men who have sex with women; MCS: 
Mental Component Scale
a. The following number of observations were missing these variables: engagement in care (3 observations), HIV-related
stigma (31 observations), and social support (3 observations)
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Table IV: Multivariable linear regression models describing the relationship between life chaos,
social support, and HIV-related stigma with ART adherence among HIV-positive cis-men and
transgender women prior to incarceration in LA County Jail (N = 198)a
Variables Bivariate analyses Multivariable model
b (95% CI) b (95% CI)
Intercept 126.91 (72.22, 181.61)***
Life Chaos -12.61 (-19.43, -
5.78)***
-8.68 (-16.90, -0.46)* 
Social support 2.46 (-1.85, 6.78) 0.11 (-4.46, 4.67)
HIV Stigma -8.10(-14.97, -1.23)* -5.35 (-13.11, 2.41)
Age 0.26 (-0.29, 0.81) -0.13 (-0.72, 0.46)
Race/ethnicity
Black -8.48 (-19.15, 2.18) -11.64 (-26.24, 2.96)
Hispanic -9.83 (-24.65, 4.98) -7.98 (-23.47, 7.51)
Other (ref)
Risk/gender group
MTF -19.33 (-39.27, 0.60) -13.35 (-34.43, 7.73)
MSM -16.21 (-30.81, -
1.61)*
-17.68 (-34.65,-0.70)*
Injection drug use -4.28 (-23.76, 15.20) -6.83 (-27.70, 14.05)
MSF (ref)
Educational 
attainment
31
Did not complete 
high school (ref)
Completed high 
school
2.22 (-9.31, 13.76) 5.42 (-6.46, 17.30)
Income
$10,000 or less 
(ref)
Greater than 
$10,000
1.91 (-9.38, 13.21) -0.97 (-12.59, 10.65)
Health insurance
No health 
insurance (ref)
Public insurance -12.53 (-24.37, -
0.69)* 
-14.28 (-26.09, -2.47)*
Private insurance -6.79 (-24.92, 11.34) -7.53 (-25.76, 10.69)
SF12 MCS 0.54 (0.10, 0.99)* 0.20 (-0.30, 0.69)
* = p<0.05, ** = p <0.01, *** = p<0.001
MTF: male to female transgender; MSM: men who have sex with men; MSF: men who have sex with 
women; MCS: Mental Component Scale
a. The following number of observations were missing these variables: ART adherence (90 
observations, 24 observations not prescribed ART), HIV-related stigma (31 observations), and social 
support (3 observations)
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